Skip to main content
Terug
Watch Compare

ETHEMA HEALTH Corp

Datakwaliteit: 100%
GRST
OTC Services Health Services
€ 0,00
€ 0,00 (0,00%)
Marktkapitalisatie: 2,32 M
Prijs
€ 0,00
Marktkapitalisatie
2,32 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Revenue grew 105,26% annually over 5 years — strong growth
Earnings declined -315,21% over the past year
Negative free cash flow of -550.338,0
Revenue growth is decelerating — 1Y growth trails 5Y average by 92,68%
Capital efficient — spends only 0,87% of revenue on capex
ROIC of 0,02% — low return on invested capital

Groei

Revenue Growth (5Y)
105,26%
Boven sectorgemiddelde (4,21%)
Revenue (1Y)12,58%
Earnings (1Y)-315,21%
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROIC0,02%
Net Margin-9,34%
Op. Margin0,03%

Veiligheid

Debt / Equity
N/A
Current Ratio0,18
Interest CoverageN/A

Waardering

PE (TTM)
-1,61
Onder sectorgemiddelde (-1,17)
P/B RatioN/A
EV/EBITDA7,24
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Services sector mediaan (502 peers)
Metriek Aandeel Sector Mediaan
P/E -1,6 -1,2
P/B — 1,4
ROE % — -16,0
Net Margin % -9,3 -18,3
Rev Growth 5Y % 105,3 4,2
D/E — 0,4

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Geen toekomstige schattingen beschikbaar

All Fundamental Metrics
Growth
Revenue Growth (1Y) 12,58% Revenue Growth (3Y) 11,72%
Earnings Growth (1Y) -315,21% Earnings Growth (3Y) N/A
Revenue Growth (5Y) 105,26% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 15,42 M Net Income (TTM) -1,44 M
ROE N/A ROA -4,87%
Gross Margin N/A Operating Margin 0,03%
Net Margin -9,34% Free Cash Flow (TTM) -550.338,0
ROIC 0,02% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,18
Interest Coverage N/A Asset Turnover 0,52
Working Capital -12,15 M Tangible Book Value -15,18 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,61 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0,15
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 7,24 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -23,74%
Market Cap 2,32 M Enterprise Value 5,30 M
Per Share
EPS (Diluted TTM) 0,00 Revenue / Share 0,00
FCF / Share 0,00 OCF / Share 0,00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,87% FCF Conversion 38,21%
SBC-Adj. FCF N/A Growth Momentum -92,68

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 6,02 M 5,34 M 4,82 M 1,94 M 338.996,0
Net Income -2,17 M 1,01 M 247.880,0 -1,54 M 3,08 M
EPS (Diluted) 0,00 — — — —
Gross Profit — — — — —
Operating Income -1,33 M -541.920,0 489.117,0 2.105,0 -163.344,0
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A 466.952,0 498.919,0 540.119,0 325.350,0 121.276,0
Interest Expense — — — -829.525,0 631.425,0
Income Tax -391.962,0 391.962,0 -112.220,0 -280.903,0 —

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 12,16 M 11,52 M 6,56 M 6,55 M 3,82 M
Total Liabilities 19,62 M 17,72 M 15,40 M 16,01 M 18,45 M
Shareholders' Equity -7,46 M -6,20 M -10,10 M -10,68 M -15,73 M
Total Debt 2,58 M 680.672,0 460.534,0 122.167,0 —
Cash & Equivalents 244.771,0 68.573,0 140.757,0 48.822,0 90.500,0
Current Assets 528.758,0 403.100,0 542.896,0 271.799,0 935.152,0
Current Liabilities 9,65 M 8,30 M 13,29 M 13,52 M 13,86 M